Vitamin D structure noting areas of chemical modification
Illustration of increase in bone volume of tibia after treatment with vitamin D analog
Ribbon structure of vitamin D receptor
Radio labeled calcitriol in intestine represented by black granules
                   
 

Deltanoid Pharmaceuticals is a company developing treatments for renal disease, osteoporosis, skin disease, and other targets. The company specializes in selecting vitamin D analogs with unique attributes and is developing them for use in specific disease areas. Deltanoid is currently developing therapies through early stage human trials and is actively seeking partners to conduct later stage human trials and commercialize the products.

 
 
 
1603 Monroe Street, Madison, WI 53711 Phone: (608) 238-7710 Fax: (608) 238-7715 info@deltanoid.com